Association de biothérapies au cours des maladies inflammatoires chroniques intestinales: Quel intérêt en pratique ?

Translated title of the contribution: Combining biologics in inflammatory bowel disease: Is it useful?

Jerôme Filippi*, Shomron Ben-Horin, Xavier Hebuterne, Xavier Roblin

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review


The current armamentarium for inflammatory bowel diseases has dramatically evolved those last years, as well as our therapeutic goals. However, many patients still have active diseases, highlighting unmet needs and interest for novel strategies, such as combining biologic therapies. The aim of this article is to report the current published data regarding the efficacy and safety of the combination of biologics in immune-mediated inflammatory diseases, and particularly in inflammatory bowel diseases.

Translated title of the contributionCombining biologics in inflammatory bowel disease: Is it useful?
Original languageFrench
Pages (from-to)1021-1027
Number of pages7
JournalHepato-Gastro et Oncologie Digestive
Issue number10
StatePublished - Dec 2018


  • Biotherapies
  • Inflammatory bowel diseases
  • Therapeutic strategies


Dive into the research topics of 'Combining biologics in inflammatory bowel disease: Is it useful?'. Together they form a unique fingerprint.

Cite this